NPPA issued the retail price of the Empagliflozin 10 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg+ Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer)

Feb 26, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 25, 2026, issued the retail price of the Empagliflozin 10 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg+ Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer).

The following has been stated:

Sum of MAT value considered for price calculation (in Lakhs) - 0.68

Sum of PTR per unit considered for price calculation - 27.79

The retail price for the Each film coated bilayer tablet contains: Empagliflozin 10 mg + Metformin Hydrochloride (As Extended Release) IP 1000 mg+ Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg for M/s Exemed Pharmaceuticals (Manufacturer) & M/s Primus Remedies Pvt. Ltd. (Marketer) will be Rs. 16.12/-.

[Notification No. 19(5042)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT